<DOC>
	<DOC>NCT00239265</DOC>
	<brief_summary>The purpose of this study is to determine whether Tamuslosin is effective in the treatment of lower urinary tract syndrome with female patients.</brief_summary>
	<brief_title>Tamsulosin Phase III Clinical Trial -Double-Blind, Placebo Controlled Study in Female Patients With Lower Urinary Tract Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Urologic Diseases</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Patients with urination disorder not accompanied by apparent organic or neurologic abnormality(lower urinary tract syndrome: LUTs)ï¼Ž Patients with urination disorder accompanied by apparent organic or neurologic abnormality, active urinary tract infections, severe cardiovascular, hepatic and/or kidney complications.</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>tamsulosin</keyword>
	<keyword>urinary tract diseases</keyword>
	<keyword>female</keyword>
</DOC>